Organisation paid for research Program year 2025 Source: CMS Open Payments

Cardiothoracic and Vascular Surgeons

Neither a doctor nor a teaching hospital

Research payments

$909,702

174 payments

Through program year 2025, Cardiothoracic and Vascular Surgeons is reported as receiving $909,702 in research payments, across 174 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$6,557	3
2024	Research	$109,771	24
2023	Research	$118,838	25
2022	Research	$154,331	27
2021	Research	$156,069	28
2020	Research	$119,564	26
2019	Research	$244,571	41

Breakdown

Who paid Research payments · program years 2019–2025

W. L. Gore & Associates, Inc. $287,577 47 payments
Medtronic Vascular, Inc. $208,438 44 payments
Medtronic, Inc. $199,692 46 payments
Silk Road Medical, Inc. $74,738 7 payments
Veryan Medical Incorporated $67,188 15 payments
Atricure, Inc. $33,710 4 payments
Shockwave Medical, Inc $28,659 9 payments
Laminate Medical Technologies inc. $9,700 2 payments

Studies the money was for Research payments · program years 2019–2025

Perigon $237,063 29 payments
Evaluation of the GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic Aneurysms $139,371 20 payments
APOLLO Trial $91,465 30 payments
Roadster 2 $74,738 7 payments
GREAT Global Registry for Endovascular Aortic Treatment $69,000 11 payments
ANCHOR Registry $63,683 22 payments
A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of peripheral arterial disease: MIMICS-3D-USA $36,288 4 payments
A prospective, multicentre observational study to evaluate the BioMimics 3D1 Vascular Stent System in the treatment of peripheral arterial disease: MIMICS-3D-USA $30,900 11 payments
Disrupt PAD BTK II $28,659 9 payments
Evaluation of the GORE EXCLUDER Throacoabdominal Branch Endoprothesis in the Treatment of Throacoabdominal and Pararenal Aortic Aneurysms $25,106 2 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.